These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 9933821

  • 1. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study.
    Brajenović-Milić B, Tislarić D, Bacić J, Paravić J, Slivar AE, Kapovic M, Kosec V, Ristic S, Rajhvajn B.
    Fetal Diagn Ther; 1998; 13(6):367-71. PubMed ID: 9933821
    [Abstract] [Full Text] [Related]

  • 2. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].
    Bian XM, Liu JT, Qi QW, Jiang YL, Li Y, Liu SY, Hao N, Zhou J, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Liao C, Cai Y, Wang H, Wang Z, Zhu J, Hu YL.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560
    [Abstract] [Full Text] [Related]

  • 3. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Cai Y.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
    Chao AS, Chung CL, Wu CD, Chang SD, Cheng PJ, Lin YT, Soong YK.
    Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Bowers GB.
    N Engl J Med; 1992 Aug 27; 327(9):588-93. PubMed ID: 1379344
    [Abstract] [Full Text] [Related]

  • 9. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 27; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 10. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
    Akbas SH, Ozben T, Alper O, Ugur A, Yücel G, Lüleci G.
    Clin Chem Lab Med; 2001 Jun 27; 39(6):487-90. PubMed ID: 11506458
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM.
    N Engl J Med; 1996 May 09; 334(19):1231-6. PubMed ID: 8606718
    [Abstract] [Full Text] [Related]

  • 14. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
    Spencer K.
    Br J Obstet Gynaecol; 1999 Dec 09; 106(12):1287-93. PubMed ID: 10609723
    [Abstract] [Full Text] [Related]

  • 15. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N, Densem J, Stone R, Cheng R.
    Br J Obstet Gynaecol; 1993 Jun 09; 100(6):550-7. PubMed ID: 7687460
    [Abstract] [Full Text] [Related]

  • 16. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology.
    Hu H, Jiang Y, Zhang M, Liu S, Hao N, Zhou J, Liu J, Zhang X, Ma L.
    Exp Biol Med (Maywood); 2017 Mar 09; 242(5):547-553. PubMed ID: 28056555
    [Abstract] [Full Text] [Related]

  • 17. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS, Huang YY, Hwa KY, Cheng CC, Lee FK.
    J Formos Med Assoc; 2001 May 09; 100(5):319-25. PubMed ID: 11432311
    [Abstract] [Full Text] [Related]

  • 18. SURUSS in perspective.
    Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A.
    Semin Perinatol; 2005 Aug 09; 29(4):225-35. PubMed ID: 16104673
    [Abstract] [Full Text] [Related]

  • 19. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM.
    J Med Screen; 1998 Aug 09; 5(3):115-9. PubMed ID: 9795869
    [Abstract] [Full Text] [Related]

  • 20. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC, Wald NJ, Smith D, Kennard A, Densem J.
    Prenat Diagn; 1996 Aug 09; 16(8):691-8. PubMed ID: 8878277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.